To be clear: he has repeatedly said that it is "too early to say" which company is in the lead -- in the Anti-PD-1 candidates' race, at the FDA's filing window.
I don't imagine that he'll discuss Merck's nascent Zen approach to IP problems, in India -- as that is not technically within his portfolio of responsibilities at Whitehouse Station. But one can hope. Here are the details; You are welcome to listen in to the web-cast.
. . . .Dr. Roger M. Perlmutter, president, Merck Research Laboratories, is scheduled to speak at the Citi 2014 Healthcare Conference in New York City on February 24, 2014 at 8:50 a.m. EST. Investors, analysts, members of the media and the general public are invited to join a live webcast of the presentation. . . .
In general, I expected -- and he is saying -- nothing Earth-shattering. And I do not expect a Consumer Health announcement of any kind -- or size, just yet. Not $6 billion; and certainly not $12 billion -- not just yet. Maybe toward the end of March 2014. In the meantime, be excellent to one another. [BTW, this is post No. 2,001 -- just since the merger was first announced. It is post No. 2,875 overall.]
No comments:
Post a Comment